This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Planning a vacation savings plan can help you reach your travel goals. Discover effective strategies to save for your next adventure.
19,232 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
In a volatile stretch for investors, Tesla’s AI chip plant plans sparked a rally in the stock market today, march. Th...
A sharp 20% plunge in Circle tokens sparked by yield shifts under a new Clarity Act framework. This morning minute re...
In 2026, savvy investors favor dividend stocks that reliably pay and grow. This article highlights two no-brainer div...
A short pause in ETF inflows didn’t last long. The latest move shows bitcoin etfs draw investment back into focus, as...
As Medicare costs rise with MAGI, retirees are turning to a tax-efficient move: roll assets from a traditional 401K t...
MercadoLibre has faced headwinds, but its long-term potential remains intact. Explore three strong reasons to conside...
A rising iPhone upgrade cycle is quietly lifting a little-known stock. This article breaks down why the move makes it...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
JPMorgan Chase has built a long runway of dividend growth, but is it the best dividend stock in banking for your port...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...